Table 4.
Predictors for persistent hyperparathyroidism.
| Characteristic | Odds ratio (95% CI) | P value |
|---|---|---|
| Age | ||
| <51 y | Reference | — |
| ≥51 y | 1.3 (0.5–3.8) | 0.5526 |
|
| ||
| Duration of dialysis pretransplantation | ||
| <3 y | Reference | — |
| ≥3 y | 5.1(1.7–15.2) | 0.0033 |
|
| ||
| PTH before | ||
| <215 ng/mL | Reference | — |
| ≥215 ng/mL | 1.2 (0.4–3.3) | 0.7581 |
Persistent hyperparathyroidism includes hyperparathyroidism which needed either medication of calcimimetic, vitamin D, bisphosphonate, denosumab, and/or parathyroidectomy after renal transplantation. Bold values are those found to be significant; p value < 0.05. RT, renal transplantation; PTH, parathyroid hormone.